Incannex Healthcare (IXHL) Proxy Filing summary

Executive summary

• Special meeting to be held virtually to vote on five key proposals, including major share issuances, charter amendments, and equity plan changes.

• Proposals are designed to comply with Nasdaq rules, support future financings, and maintain listing requirements.

• Board recommends approval of all proposals to ensure operational flexibility and continued access to capital.

Voting matters and shareholder proposals

• Proposal 1: Approve issuance of up to 347,222,700 shares underlying Series A Warrants from a March 2025 private placement, subject to Nasdaq Listing Rule 5635(d).

• Proposal 2: Amend charter to increase authorized common stock from 100,000,000 to 800,000,000 shares.

• Proposal 3: Amend 2023 Equity Incentive Plan to add 2,700,000 shares and an evergreen provision for future increases.

• Proposal 4: Approve a reverse stock split at a ratio between 1-for-2 and 1-for-50, with the board setting the exact ratio.

• Proposal 5: Approve adjournment of the meeting if more time is needed to solicit votes.

• Board recommends voting FOR all proposals.

Board of directors and corporate governance

• Board retains discretion to set the reverse split ratio and to abandon the split if deemed not in the best interest of shareholders.

• Board and compensation committee oversee the equity incentive plan and its amendments.

• No director or executive officer has a substantial interest in the proposals beyond their employment and shareholdings.